These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 26807479)

  • 1. Interactions of human P-glycoprotein transport substrates and inhibitors at the drug binding domain: Functional and molecular docking analyses.
    Kadioglu O; Saeed ME; Valoti M; Frosini M; Sgaragli G; Efferth T
    Biochem Pharmacol; 2016 Mar; 104():42-51. PubMed ID: 26807479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N,N-bis(cyclohexanol)amine aryl esters inhibit P-glycoprotein as transport substrates.
    Neri A; Frosini M; Valoti M; Cacace MG; Teodori E; Sgaragli G
    Biochem Pharmacol; 2011 Dec; 82(12):1822-31. PubMed ID: 21920352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions of the multidrug resistance modulators tariquidar and elacridar and their analogues with P-glycoprotein.
    Pajeva IK; Sterz K; Christlieb M; Steggemann K; Marighetti F; Wiese M
    ChemMedChem; 2013 Oct; 8(10):1701-13. PubMed ID: 23943604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New structure-activity relationship studies in a series of N,N-bis(cyclohexanol)amine aryl esters as potent reversers of P-glycoprotein-mediated multidrug resistance (MDR).
    Orlandi F; Coronnello M; Bellucci C; Dei S; Guandalini L; Manetti D; Martelli C; Romanelli MN; Scapecchi S; Salerno M; Menif H; Bello I; Mini E; Teodori E
    Bioorg Med Chem; 2013 Jan; 21(2):456-65. PubMed ID: 23245571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rhodamine 123 requires carrier-mediated influx for its activity as a P-glycoprotein substrate in Caco-2 cells.
    Troutman MD; Thakker DR
    Pharm Res; 2003 Aug; 20(8):1192-9. PubMed ID: 12948017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MDR1 haplotypes significantly minimize intracellular uptake and transcellular P-gp substrate transport in recombinant LLC-PK1 cells.
    Salama NN; Yang Z; Bui T; Ho RJ
    J Pharm Sci; 2006 Oct; 95(10):2293-308. PubMed ID: 16883550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P-Glycoprotein (P-gp) expressed in a confluent monolayer of hMDR1-MDCKII cells has more than one efflux pathway with cooperative binding sites.
    Acharya P; Tran TT; Polli JW; Ayrton A; Ellens H; Bentz J
    Biochemistry; 2006 Dec; 45(51):15505-19. PubMed ID: 17176072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of basal, substrate induced and total P-glycoprotein activity in bronchoalveolar lavage T-cell subsets.
    Donnenberg VS; Wilson JW; Burckart GJ; Zeevi A; Iacono A; Donnenberg AD
    Cytometry A; 2004 Feb; 57(2):75-85. PubMed ID: 14750128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in respiration rate of isolated rainbow trout hepatocytes exposed to the P-glycoprotein substrate rhodamine 123.
    Bains OS; Kennedy CJ
    Toxicology; 2005 Oct; 214(1-2):87-98. PubMed ID: 16026915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and functional activity of P-glycoprotein in passaged primary human nasal epithelial cell monolayers cultured by the air-liquid interface method for nasal drug transport study.
    Cho HJ; Choi MK; Lin H; Kim JS; Chung SJ; Shim CK; Kim DD
    J Pharm Pharmacol; 2011 Mar; 63(3):385-91. PubMed ID: 21749386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of modulators to mouse and human multidrug resistance P-glycoprotein. A computational study.
    Jara GE; Vera DM; Pierini AB
    J Mol Graph Model; 2013 Nov; 46():10-21. PubMed ID: 24095875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic interaction between p-glycoprotein modulators and epirubicine on resistant cancer cells.
    Duarte N; Járdánházy A; Molnár J; Hilgeroth A; Ferreira MJ
    Bioorg Med Chem; 2008 Oct; 16(20):9323-30. PubMed ID: 18824363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the chemosensitizer verapamil on P-glycoprotein substrate efflux in rainbow trout hepatocytes.
    Johnston CU; Kennedy CJ
    Comp Biochem Physiol C Toxicol Pharmacol; 2024 Jan; 275():109763. PubMed ID: 37820937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanistic studies of the effect of bile salts on rhodamine 123 uptake into RBE4 cells.
    Yang L; Fawcett JP; Østergaard J; Zhang H; Tucker IG
    Mol Pharm; 2012 Jan; 9(1):29-36. PubMed ID: 22050323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HZ08 inhibits the multi-drug resistance on multiple sites as the substrate of p-glycoprotein.
    Feng Y; Hu Y; Cen J; Darshika KN; Fang W; Li Y; Huang W
    Eur J Pharmacol; 2013 Jul; 712(1-3):53-9. PubMed ID: 23665114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homology Modeling of the Human P-glycoprotein (ABCB1) and Insights into Ligand Binding through Molecular Docking Studies.
    Mora Lagares L; Minovski N; Caballero Alfonso AY; Benfenati E; Wellens S; Culot M; Gosselet F; Novič M
    Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32517082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P-gp activity and inhibition in the different regions of human intestine ex vivo.
    Li M; de Graaf IA; de Jager MH; Groothuis GM
    Biopharm Drug Dispos; 2017 Mar; 38(2):127-138. PubMed ID: 27757966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional assessment of multiple P-glycoprotein (P-gp) probe substrates: influence of cell line and modulator concentration on P-gp activity.
    Taub ME; Podila L; Ely D; Almeida I
    Drug Metab Dispos; 2005 Nov; 33(11):1679-87. PubMed ID: 16093365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of P-glycoprotein-mediated Multidrug Resistance (MDR) by N,N-bis(cyclohexanol)amine aryl esters: further restriction of molecular flexibility maintains high potency and efficacy.
    Martelli C; Dei S; Lambert C; Manetti D; Orlandi F; Romanelli MN; Scapecchi S; Salerno M; Teodori E
    Bioorg Med Chem Lett; 2011 Jan; 21(1):106-9. PubMed ID: 21145739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trantinterol, a novel β2-adrenoceptor agonist, noncompetitively inhibits P-glycoprotein function in vitro and in vivo.
    Wang T; Sun Y; Ma W; Yang Z; Yang J; Liu J; Fan H; Yang Y; Gu J; Fawcett JP; Guo Y
    Mol Pharm; 2015 Jan; 12(1):1-9. PubMed ID: 25389765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.